| Eli Lilly (Suisse) SA - Mounjaro 12.5 mg, solution for injection in vial | | 69415 | | 05 | | Mounjaro 12.5 mg | | solution for injection in vial | | A10BX | | Other Blood Glucose Lowering Drugs, Excl. Insulins | | 09.07.2024 | | |
| | Composition | | tirzepatidum 12.5 mg, dinatrii phosphas heptahydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 0.5 ml corresp. natrium 1.8 - 1.9 mg. | | Packungsbestandteile | | solution for injection in vial | | | | | | Active Agent | Dose |
|---|
| Tirzepatidum | 12.5mg / 0.5ml |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Disodium Phosphate Heptahydrate | | Sodium Chloride | | Sodium Hydroxide |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | | PR | PR | B | | No | | 011 | 4 | PR | PR | B | | No |
|
|
